APYX MEDICAL CORP (APYX) Stock Institutional Trading Activity


APYX MEDICAL CORP (APYX) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q4 2025), investors with some of the largest reported share count changes include Renaissance Technologies LLC. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q4 2025Renaissance Technologies LLCSell-1,302220,395$771,383
Q3 2025Renaissance Technologies LLCBuy40,302221,697$474,432
Q2 2025Renaissance Technologies LLCSell-20,600181,395$408,139
Q1 2025Renaissance Technologies LLCSell-4,200201,995$276,733
Q4 2024Renaissance Technologies LLCBuy2,900206,195$325,788
Q3 2024Renaissance Technologies LLCSell-13,298203,295$252,086
Q2 2024Renaissance Technologies LLCSell-35,424216,593$290,235
Q1 2024Renaissance Technologies LLCSell-118,486252,017$343
Q4 2023Renaissance Technologies LLCSell-33,904370,503$971
Q3 2023Renaissance Technologies LLCBuy118,912404,407$1,294
Q2 2023Renaissance Technologies LLCSell-45,600285,495$1,436
Q1 2023Renaissance Technologies LLCSell-37,100331,095$954
Q4 2022Renaissance Technologies LLCSell-59,900368,195$862
Q3 2022Renaissance Technologies LLCSell-113,888428,095$1,922
Q2 2022Renaissance Technologies LLCBuy29,977541,983$3,176
Q1 2022Renaissance Technologies LLCBuy28,211512,006$3,343
Q4 2021Renaissance Technologies LLCSell-100483,795$6,202
Q3 2021Renaissance Technologies LLCSell-35,100483,895$6,702
Q2 2021Renaissance Technologies LLCBuy5,200518,995$5,351
Q1 2021Renaissance Technologies LLCSell-40,600513,795$4,963
Q4 2020Renaissance Technologies LLCSell-5,400554,395$3,992
Q3 2020Renaissance Technologies LLCSell-22,400559,795$2,637
Q2 2020Renaissance Technologies LLCSell-55,400582,195$3,231
Q1 2020Renaissance Technologies LLCBuy14,700637,595$2,289
Q4 2019Renaissance Technologies LLCSell-29,905622,895$5,270
Q3 2019Renaissance Technologies LLCSell-13,800652,800$4,419
Q2 2019Renaissance Technologies LLCSell-9,507666,600$4,480
Q1 2019Renaissance Technologies LLCBuy676,107676,107$4,266

Frequently asked questions about APYX activity

  • Which institutional owners are buying APYX?

    Institutional owners buying APYX include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in APYX activity?

    "Buy" means an investor increased their reported position in APYX compared to the prior reporting period. This reflects growing exposure to APYX MEDICAL CORP (APYX) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in APYX increasing?

    Institutional interest in APYX can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.